He also leads the Cognition Cores for the Dominantly-Inherited Alzheimer Network-Trials Unit (DIAN-TU) and the DIAN observational study and the Charles F. and Joanne Knight Alzheimer’s Disease Research Center. The CTRLab’s focus in on using technology to improve cognitive assessments in Alzheimer’s disease and other disorders. We use measurement burst designs, based on principles from ecological momentary assessment, to measure cognition rapidly and frequently on smartphones in normal and clinical populations. We also develop web-based cognitive assessments designed to be sensitive to the very earliest stages of neurodegenerative disease. Dr. Hassenstab has been continuously funded by the NIH since 2007 and also receives funding from foundations. His most recent projects include development of the Ambulatory Research in Cognition (ARC) smartphone application for the DIAN observational study, the DIAN-TU Phase III clinical trials, and the Healthy Aging and Senile Dementia program project grant at the Knight ADRC.